Inside Geneva's Sprint to Support COVID-19 Vaccines
How we helped support the largest vaccine effort in history
OPERATION WARP SPEED
COVID-19 RESPONSE OPERATION
When the federal government unveiled Operation Warp Speed (OWS) in May 2020, it was “unlike anything our country has seen since the Manhattan Project.” The multi-agency initiative’s central goal - to develop, produce, and distribute 300 million doses of a safe and effective coronavirus vaccine by January 2021 - requires a deep knowledge of science and how to manage complex government operations while navigating a challenging pandemic.
In this Case Study, you will find:
- Benefits of working with military populations in clinical trials
- Map of military treatment facilities Geneva is working with to advance Operation Warp Speed
- Timeline of clinical trials
- Regulatory expertise
- Types of positions needed to support OWS
Geneva is proud to have over 25 years of experience in delivering full-spectrum scientific, technical, and program management expertise in the areas of federal contracts, federal grants, and industry-sponsored clinical trials.
Geneva is a 501(c)3 non-profit organization that advances military medicine through innovative scientific research, exceptional program management, and a dedication to U.S. service members and veterans, their families, and the global community.